Literature DB >> 10725701

IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.

S Aung1, B S Graham.   

Abstract

CTL have evolved two major mechanisms for target cell killing: one mediated by perforin/granzyme secretion and the other by Fas/Fas ligand (L) interaction. Although cytokines are integral to the development of naive CTL into cytolytic effectors, the role of cytokines on mechanisms of CTL killing is just emerging. In this study, we evaluate the effects of IL-4 in Fas(CD95)/FasL(CD95L)-mediated killing of Fas-overexpressing target cells. Recombinant vaccinia viruses (vv) were constructed to express respiratory syncytial virus M2 Ag alone (vvM2) or coexpress M2 and IL-4 (vvM2/IL-4). MHC-matched Fas-overexpressing target cells (L1210Fas+) were used to measure both perforin- and FasL-mediated killing pathways. In contrast to Fas-deficient (L1210Fas-) target cells, effectors from vvM2/IL-4-immunized mice were able to lyse L1210Fas+ target cells with similar magnitude as vvM2-infected mice. Addition of EGTA/Mg2+ revealed that effectors from vvM2/IL-4-infected mice primarily lyse targets by a Ca2+-independent Fas/FasL pathway. Analysis of FasL expression by flow cytometry showed that IL-4 increased cell surface FasL expression on CD4+ and CD8+ splenocytes, with peak expression on day 4 after infection. These data demonstrate that IL-4 increases FasL expression on T cells, resulting in a shift of the mechanism of CTL killing from a dominant perforin-mediated cytolytic pathway to a dominant FasL-mediated cytolytic pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725701     DOI: 10.4049/jimmunol.164.7.3487

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Creation of killer poxvirus could have been predicted.

Authors:  A Müllbacher; M Lobigs
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity.

Authors:  Kazuyuki Akane; Seiji Kojima; Tak W Mak; Hiroshi Shiku; Haruhiko Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-11       Impact factor: 11.205

3.  A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.

Authors:  Badiga Venkata Aruna; Hava Ben-David; Michael Sela; Edna Mozes
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

4.  Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.

Authors:  Bo Chi; Harold L Dickensheets; Kirsten M Spann; Marc A Alston; Cindy Luongo; Laure Dumoutier; Jiaying Huang; Jean-Christophe Renauld; Sergei V Kotenko; Mario Roederer; Judy A Beeler; Raymond P Donnelly; Peter L Collins; Ronald L Rabin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 5.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.

Authors:  S Aung; J A Rutigliano; B S Graham
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cells.

Authors:  G Z Tau; S N Cowan; J Weisburg; N S Braunstein; P B Rothman
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

Review 8.  Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.

Authors:  Barney S Graham
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

9.  Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.

Authors:  Lewis H McCurdy; John A Rutigliano; Teresa R Johnson; Man Chen; Barney S Graham
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits.

Authors:  Marianne M Stanford; John W Barrett; Philippe-Alexandre Gilbert; Richard Bankert; Grant McFadden
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.